88 related articles for article (PubMed ID: 4049780)
1. [Water-soluble modified derivatives of urokinase: fibrinolytic activity and other properties].
Maksimenko AV; Torchilin VP
Vopr Med Khim; 1985; 31(4):12-20. PubMed ID: 4049780
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble urokinase derivatives of combined action.
Maksimenko AV; Torchilin VP
Thromb Res; 1985 May; 38(3):277-88. PubMed ID: 4024043
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic activity of immobilized plasminogen activator.
Senatore FF; Bernath FR
Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):295-304. PubMed ID: 4059655
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic mechanisms of urokinase immobilized polyurethane.
Kitamoto Y; Tomita M; Kiyama S; Inoue T; Yabushita Y; Sato T; Ryoda H; Sato T
Thromb Haemost; 1991 Jan; 65(1):73-6. PubMed ID: 2024241
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
6. [Blood coagulating properties of immobilized proteases].
Zubairov DM; Zinkevich OD
Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
[TBL] [Abstract][Full Text] [Related]
7. Immobilization of plasminogen activator, urokinase, on nylon.
Sugitachi A; Takagi K; Imaoka S; Kosaki G
Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
[TBL] [Abstract][Full Text] [Related]
8. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
[TBL] [Abstract][Full Text] [Related]
9. Water-soluble urokinase derivatives with increased affinity to the fibrin clot.
Maksimenko AV; Torchilin VP
Thromb Res; 1985 May; 38(3):289-95. PubMed ID: 4024044
[TBL] [Abstract][Full Text] [Related]
10. [Immobilized thrombolytic enzymes and their use in ophthalmology].
Samsonov GV; Danilichev VF; Kol'tsova SV
Vopr Med Khim; 1985; 31(4):51-4. PubMed ID: 4049787
[TBL] [Abstract][Full Text] [Related]
11. [Thrombolytic action of urokinase preparation covalently bound to modified thrombin].
Maksimenko AV; Tishvhenko EG; Petrov AD; Orekhova NM; Ragimov SE
Biull Eksp Biol Med; 1988 Sep; 106(9):322-4. PubMed ID: 3167185
[TBL] [Abstract][Full Text] [Related]
12. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
13. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
Ueno T; Kobayashi N; Maekawa T
Thromb Haemost; 1979 Oct; 42(3):885-94. PubMed ID: 505403
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi.
Tanaka K; Einaga K; Tsuchiyama H; Tait JF; Fujikawa K
Biochemistry; 1996 Jan; 35(3):922-9. PubMed ID: 8547274
[TBL] [Abstract][Full Text] [Related]
15. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material.
Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
J Biomed Mater Res; 1981 Jul; 15(4):553-63. PubMed ID: 7024280
[TBL] [Abstract][Full Text] [Related]
16. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
17. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of urokinase type plasminogen activator modified by phenylglyoxal].
Mukhametova LI; Aĭsina RB; Lomakina GIu; Varfolomeev SD
Bioorg Khim; 2002; 28(4):308-14. PubMed ID: 12197387
[TBL] [Abstract][Full Text] [Related]
19. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
20. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
